Follow-up of blood-pressure lowering and glucose control in type 2 diabetes
Background In the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) factorial trial, the combination of perindopril and indapamide reduced mortality among patients with type 2 diabetes, but intensive glucose control, targeting a glycated hemoglobin level of less than 6.5%, did not. We now report results of the 6-year post-trial follow-up.Methods We invited surviving participants, who had previously been assigned to perindopril-...[Show more]
|Collections||ANU Research Publications|
|Source:||New England Journal of Medicine|
|01_Zoungas_Follow-up_of_blood-pressure_2014.pdf||2.53 MB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.